抗レトロウイルス薬へのアクセス、女性 (%)の世界ランキング2000〜2022年【国別順位】
2000〜2022年の抗レトロウイルス薬へのアクセス、女性 (%)について、各国の世界ランキングを表形式にして、国別順位をまとめました。
2022年の1位はボツワナで98、2位はブルキナファソで98、3位はマラウイで98でした。
HIV とともに生存し、抗レトロウイルス療法を受けている成人女性の割合。
【英語版はこちら】
抗レトロウイルス薬へのアクセス、女性 (%)の国別の推移グラフ【2000〜2022年】
抗レトロウイルス薬へのアクセス、女性 (%)
抗レトロウイルス薬へのアクセス、女性 (%)の世界ランキング 2022
表示年度: 2022年
-
+
| 順位 | 国 | 抗レトロウイルス薬へのアクセス、女性 (%) | 前年比 | |
|---|---|---|---|---|
| 検索: | ||||
| 1 | 98 | 1.03% | ||
| 1 | 98 | 6.52% | ||
| 1 | 98 | 3.16% | ||
| 1 | 98 | 3.16% | ||
| 1 | 98 | 7.69% | ||
| 6 | 97 | 8.99% | ||
| 6 | 97 | 6.59% | ||
| 6 | 97 | 1.04% | ||
| 6 | 97 | 4.30% | ||
| 10 | 96 | 10.34% | ||
| 11 | 95 | 3.26% | ||
| 11 | 95 | 21.79% | ||
| 13 | 94 | 4.44% | ||
| 13 | 94 | 9.30% | ||
| 15 | 93 | 2.20% | ||
| 16 | 92 | 1.10% | ||
| 16 | 92 | 6.98% | ||
| 16 | 92 | 5.75% | ||
| 19 | 91 | 12.35% | ||
| 19 | 91 | 3.41% | ||
| 21 | 90 | |||
| 22 | 89 | 3.49% | ||
| 22 | 89 | 2.30% | ||
| 24 | 88 | 10.00% | ||
| 24 | 88 | 6.02% | ||
| 24 | 88 | 2.33% | ||
| 27 | 86 | 2.38% | ||
| 27 | 86 | 4.88% | ||
| 27 | 86 | -1.15% | ||
| 30 | 85 | 2.41% | ||
| 30 | 85 | 4.94% | ||
| 32 | 83 | 13.70% | ||
| 32 | 83 | 2.47% | ||
| 32 | 83 | 13.70% | ||
| 32 | 83 | 3.75% | ||
| 36 | 81 | 12.50% | ||
| 37 | 80 | 5.26% | ||
| 37 | 80 | 6.67% | ||
| 37 | 80 | 2.56% | ||
| 37 | 80 | 1.27% | ||
| 41 | 79 | 1.28% | ||
| 41 | 79 | 3.95% | ||
| 41 | 79 | 2.60% | ||
| 44 | 78 | 2.63% | ||
| 44 | 78 | 8.33% | ||
| 46 | 77 | 2.67% | ||
| 47 | 75 | 13.64% | ||
| 47 | 75 | 1.35% | ||
| 49 | 74 | -2.63% | ||
| 49 | 74 | 2.78% | ||
| 49 | 74 | 10.45% | ||
| 52 | 73 | 4.29% | ||
| 52 | 73 | 1.39% | ||
| 52 | 73 | 4.29% | ||
| 55 | 72 | 5.88% | ||
| 55 | 72 | |||
| 55 | 72 | 1.41% | ||
| 58 | 69 | -4.17% | ||
| 58 | 69 | 11.29% | ||
| 58 | 69 | 1.47% | ||
| 61 | 68 | |||
| 62 | 67 | 8.06% | ||
| 62 | 67 | 1.52% | ||
| 62 | 67 | 1.52% | ||
| 62 | 67 | 8.06% | ||
| 66 | 66 | -2.94% | ||
| 67 | 65 | 20.37% | ||
| 67 | 65 | |||
| 69 | 64 | 4.92% | ||
| 69 | 64 | |||
| 71 | 63 | 8.62% | ||
| 71 | 63 | |||
| 71 | 63 | 6.78% | ||
| 74 | 62 | 5.08% | ||
| 75 | 61 | 8.93% | ||
| 76 | 60 | -6.25% | ||
| 76 | 60 | 3.45% | ||
| 76 | 60 | -3.23% | ||
| 79 | 59 | 5.36% | ||
| 80 | 58 | 7.41% | ||
| 80 | 58 | 26.09% | ||
| 82 | 57 | 9.62% | ||
| 82 | 57 | 1.79% | ||
| 82 | 57 | -3.39% | ||
| 85 | 56 | 9.80% | ||
| 86 | 55 | 5.77% | ||
| 86 | 55 | 10.00% | ||
| 86 | 55 | 3.77% | ||
| 86 | 55 | 5.77% | ||
| 90 | 54 | 12.50% | ||
| 90 | 54 | 5.88% | ||
| 92 | 53 | 8.16% | ||
| 92 | 53 | 12.77% | ||
| 92 | 53 | -7.02% | ||
| 95 | 51 | -7.27% | ||
| 96 | 50 | -1.96% | ||
| 97 | 49 | |||
| 97 | 49 | 8.89% | ||
| 97 | 49 | 13.95% | ||
| 100 | 48 | 4.35% | ||
| 100 | 48 | 20.00% | ||
| 100 | 48 | 9.09% | ||
| 103 | 47 | 9.30% | ||
| 103 | 47 | 2.17% | ||
| 105 | 46 | -8.00% | ||
| 106 | 43 | 19.44% | ||
| 107 | 41 | 10.81% | ||
| 108 | 40 | 37.93% | ||
| 108 | 40 | -4.76% | ||
| 110 | 37 | -9.76% | ||
| 111 | 36 | 2.86% | ||
| 112 | 34 | 6.25% | ||
| 113 | 33 | -2.94% | ||
| 114 | 29 | 16.00% | ||
| 115 | 28 | -3.45% | ||
| 116 | 26 | 13.04% | ||
| 117 | 25 | 13.64% | ||
| 117 | 25 | -32.43% | ||
| 119 | 23 | 4.55% | ||
| 120 | 17 | 13.33% | ||
| 121 | 15 | 25.00% | ||
| 122 | 12 | 20.00% | ||
| 123 | 10 | |||